Literature DB >> 2846114

Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome.

A J Cole1, R Kuzniecky, G Karpati, S Carpenter, E Andermann, F Andermann.   

Abstract

Five of 6 male siblings were affected by a progressive myopathy beginning in early childhood. Muscle biopsies in all patients showed the characteristic changes of inclusion body myositis. Computerized tomography and magnetic resonance imaging revealed a markedly abnormal appearance of cerebral white matter in the 4 affected patients tested, but clinical and other laboratory examinations failed to demonstrate evidence of central white matter dysfunction. Muscle biopsies and brain imaging were normal in all clinically unaffected family members. On the basis of the genetics, muscle biopsy findings and cerebral white matter changes, we conclude that this constellation represents a hitherto undescribed syndrome.

Entities:  

Mesh:

Year:  1988        PMID: 2846114     DOI: 10.1093/brain/111.5.1025

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

Review 1.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Intranuclear and cytoplasmic filamentous inclusions in distal myopathy (Welander).

Authors:  K Borg; F M Tomé; L Edström
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Glucocorticoid-sensitive hereditary inclusion body myositis.

Authors:  M Naumann; H Reichmann; H H Goebel; C Moll; K V Toyka
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

4.  Mitochondrial encephalomyopathy--two years follow-up by MRI.

Authors:  K A Hausegger; M M Millner; F Ebner; F Flückiger; E Justich
Journal:  Pediatr Radiol       Date:  1991

5.  Inflammatory and non-inflammatory inclusion body myositis. Characterization of the mononuclear cells and expression of the immunoreactive class I major histocompatibility complex product.

Authors:  D Figarella-Branger; J F Pellissier; N Bianco; B Devictor; M Toga
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau.

Authors:  V Askanas; W K Engel; M Bilak; R B Alvarez; D J Selkoe
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

7.  Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis.

Authors:  J Nalbantoglu; G Karpati; S Carpenter
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

8.  Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis.

Authors:  V Askanas; W K Engel; R B Alvarez
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

9.  Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis.

Authors:  M Bilak; V Askanas; W K Engel
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Inclusion body myositis: clinical and histopathological features of 36 patients.

Authors:  S Beyenburg; S Zierz; F Jerusalem
Journal:  Clin Investig       Date:  1993-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.